GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Human Xtensions Ltd (XTAE:HUMX) » Definitions » Debt-to-EBITDA

Human Xtensions (XTAE:HUMX) Debt-to-EBITDA : -0.05 (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Human Xtensions Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Human Xtensions's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₪0.97 Mil. Human Xtensions's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₪0.72 Mil. Human Xtensions's annualized EBITDA for the quarter that ended in Dec. 2023 was ₪-31.50 Mil. Human Xtensions's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was -0.05.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Human Xtensions's Debt-to-EBITDA or its related term are showing as below:

XTAE:HUMX' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -0.29   Med: -0.09   Max: -0.05
Current: -0.05

During the past 6 years, the highest Debt-to-EBITDA Ratio of Human Xtensions was -0.05. The lowest was -0.29. And the median was -0.09.

XTAE:HUMX's Debt-to-EBITDA is ranked worse than
100% of 434 companies
in the Medical Devices & Instruments industry
Industry Median: 1.26 vs XTAE:HUMX: -0.05

Human Xtensions Debt-to-EBITDA Historical Data

The historical data trend for Human Xtensions's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Human Xtensions Debt-to-EBITDA Chart

Human Xtensions Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
Get a 7-Day Free Trial -0.09 -0.29 -0.12 -0.07 -0.05

Human Xtensions Quarterly Data
Dec18 Jun19 Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.07 -0.07 -0.06 -0.07 -0.05

Competitive Comparison of Human Xtensions's Debt-to-EBITDA

For the Medical Devices subindustry, Human Xtensions's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Human Xtensions's Debt-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Human Xtensions's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Human Xtensions's Debt-to-EBITDA falls into.



Human Xtensions Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Human Xtensions's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.966 + 0.724) / -34.543
=-0.05

Human Xtensions's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.966 + 0.724) / -31.496
=-0.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2023) EBITDA data.


Human Xtensions  (XTAE:HUMX) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Human Xtensions Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Human Xtensions's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Human Xtensions (XTAE:HUMX) Business Description

Traded in Other Exchanges
N/A
Address
Meir Ariel 4, Tel Aviv, ISR
Human Xtensions Ltd is engaged in the business of developing handheld digital solutions for minimally invasive surgery. It develops unmediated surgical systems that combine the capacity of robotics with the benefits of handheld tools and ergonomic bed mounts. The company's product, HandX, is designed as a light-weight, hand-held device that translates the surgeon's natural hand motions into complex movements inside the patient.

Human Xtensions (XTAE:HUMX) Headlines

No Headlines